Per ulteriori informazioni selezionare i riferimenti di interesse.
AIDS-related Kaposi's sarcoma: A phase II study of liposomal doxorubicin
CLINICAL CANCER RESEARCH
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, andfluorouracil as first-line therapy in patients with metastatic breast cancer
JOURNAL OF CLINICAL ONCOLOGY
Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer
JOURNAL OF CLINICAL ONCOLOGY
A PHASE-II STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN), IN COMBINATION WITH (5-FU) AND CYCLOPHOSPHAMIDE (CPA) IN THE TREATMENT OFMETASTATIC BREAST-CANCER (MBC)
Annals of oncology
A PHASE-I STUDY OF TLC D-99 (LIPOSOME-ENCAPSULATED DOXORUBICIN) WITH G-CSF IN PATIENTS WITH REFRACTORY SOLID TUMORS
Annals of oncology
MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER
American journal of clinical oncology